Patents by Inventor David Ingram
David Ingram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11408554Abstract: A gantry-type positioning device includes first and second cross members. Two linear guides are disposed parallel to each other on a base and support the first and second cross members such that the cross members are movable in a first direction. A Y-carriage has a functional element and is supported on the first cross member such that the Y-carriage and the functional element are movable in a second direction. A position-measuring device is disposed on the second cross member and the Y-carriage such that a position of the Y-carriage relative to the second cross member is detectable. A Z-carriage supports the functional element such that the functional element is movable relative to the Y-carriage in a third direction. A further position-measuring device is disposed on the Y-carriage and the functional element such that a position of the functional element relative to the Y-carriage is detectable.Type: GrantFiled: August 8, 2018Date of Patent: August 9, 2022Assignee: ETEL S.A.Inventors: David Ingram, Laurent Heiniger
-
Patent number: 11033655Abstract: Stabilized monomer and polymer adhesive compositions useful in the formulation of biomedical adhesives and sealants for application to living tissue are provided.Type: GrantFiled: December 9, 2015Date of Patent: June 15, 2021Assignee: STRATEGIC MEDICAL SOLUTIONS, LLC.Inventors: Seth McCullen, David Ingram, Michael Aaron Vaughn, William Thomas Stephens, Jr., Melissa Vinci-Rainis, Robert Laudadio
-
Publication number: 20200268893Abstract: In situ gel-forming compositions are disclosed, which may comprise one or more absorbable polymers, solvents such as N-methyl-2-pyrrolidone, polyethylene glycol or DMSO, and one or more bioactive agents. The composition forms a hydrogel or semi-solid mass on contact with an aqueous environment. Methods of using in situ gel-forming composition for various applications are also disclosed.Type: ApplicationFiled: June 29, 2018Publication date: August 27, 2020Inventors: David Ingram, Michael Aaron Vaughn, Michael Scott Taylor, Kara Bethany Acampora, David Gravett
-
Publication number: 20200238349Abstract: A process for immobilizing hazardous waste includes mixing the hazardous waste with a non-swelling clay, a cementitious binder and, optionally, water, and allowing the resulting mixture to set to an immobilized waste material. The process can also include dispersing the hazardous waste in the non-swelling clay to form a dry mixture, mixing the cementitious binder and, optionally, water with the dry mixture to produce a plastic mixture, and allowing the plastic mixture to set to the immobilized waste material.Type: ApplicationFiled: October 17, 2018Publication date: July 30, 2020Inventors: Michael David Ingram, Lincoln Morton
-
Publication number: 20190063669Abstract: A gantry-type positioning device includes first and second cross members. Two linear guides are disposed parallel to each other on a base and support the first and second cross members such that the cross members are movable in a first direction. A Y-carriage has a functional element and is supported on the first cross member such that the Y-carriage and the functional element are movable in a second direction. A position-measuring device is disposed on the second cross member and the Y-carriage such that a position of the Y-carriage relative to the second cross member is detectable. A Z-carriage supports the functional element such that the functional element is movable relative to the Y-carriage in a third direction. A further position-measuring device is disposed on the Y-carriage and the functional element such that a position of the functional element relative to the Y-carriage is detectable.Type: ApplicationFiled: August 8, 2018Publication date: February 28, 2019Inventors: David Ingram, Laurent Heiniger
-
Patent number: 9990694Abstract: Certain embodiments of this disclosure include methods and devices for outputting a zoom sequence. According to one embodiment, a method is provided. The method may include: (i) determining first location information from first metadata associated with one or more images, wherein the first location information identifies a first location; and (ii) outputting, for display, a first zoom sequence based on the first location information, wherein the first zoom sequence may include a first plurality of mapped images of the first location from a first plurality of zoom levels and the plurality of mapped images are sequentially ordered by a magnitude of the zoom level.Type: GrantFiled: November 28, 2016Date of Patent: June 5, 2018Assignee: Google LLCInventors: Thomas Weedon Hume, Mikkel Crone Köser, Tony Ferreira, Jeremy Lyon, Waldemar Ariel Baraldi, Bryan Mawhinney, Christopher James Smith, Lenka Trochtova, Andrei Popescu, David Ingram, Flavio Lerda, Michael Ananin, Vytautas Vaitukaitis, Marc Paulina
-
Publication number: 20170313808Abstract: Bioactive liquid formulations are formed of combinations of absorbable, segmented aliphatic polyurethane compositions and liquid polyether for use as vehicles for the controlled release of at least one active agent for the conventional and unconventional treatment of different forms of cancer and the management of at least one type of bacterial, fungal, and viral infection.Type: ApplicationFiled: July 17, 2017Publication date: November 2, 2017Inventors: Shalaby W. Shalaby, Joel T. Corbett, Michael Aaron Vaughn, David Ingram
-
Publication number: 20170086018Abstract: A method is provided on a server for controlling messages transmitted to an electronic device. Message preference data is retrieved from a first database. It is then determined if a message is authorised for transmission to the electronic device according to the message preference data, and if the message is determined to be authorised, the message is transmitted from the server to the electronic device. Corresponding devices, systems and computer readable media are also disclosed.Type: ApplicationFiled: March 3, 2015Publication date: March 23, 2017Inventors: Daniel Wagner, David Ingram, Michael Johns, Ian Thomas Williamson
-
Publication number: 20170076427Abstract: Certain embodiments of this disclosure include methods and devices for outputting a zoom sequence. According to one embodiment, a method is provided. The method may include: (i) determining first location information from first metadata associated with one or more images, wherein the first location information identifies a first location; and (ii) outputting, for display, a first zoom sequence based on the first location information, wherein the first zoom sequence may include a first plurality of mapped images of the first location from a first plurality of zoom levels and the plurality of mapped images are sequentially ordered by a magnitude of the zoom level.Type: ApplicationFiled: November 28, 2016Publication date: March 16, 2017Inventors: Thomas Weedon Hume, Mikkel Crone Köser, Tony Ferreira, Jeremy Lyon, Waldemar Ariel Baraldi, Bryan Mawhinney, Christopher James Smith, Lenka Trochtova, Andrei Popescu, David Ingram, Flavio Lerda, Michael Ananin, Vytautas Vaitukaitis, Marc Paulina
-
Patent number: 9508172Abstract: Certain embodiments of this disclosure include methods and devices for outputting a zoom sequence. According to one embodiment, a method is provided. The method may include: (i) determining first location information from first metadata associated with one or more images, wherein the first location information identifies a first location; and (ii) outputting, for display, a first zoom sequence based on the first location information, wherein the first zoom sequence may include a first plurality of mapped images of the first location from a first plurality of zoom levels and the plurality of mapped images are sequentially ordered by a magnitude of the zoom level.Type: GrantFiled: December 5, 2013Date of Patent: November 29, 2016Assignee: Google Inc.Inventors: Thomas Weedon Hume, Mikkel Crone Koser, Tony Ferreira, Jeremy Lyon, Waldemar Ariel Baraldi, Bryan Mawhinney, Christopher James Smith, Lenka Trochtova, Andrei Popescu, David Ingram, Flavio Lerda, Michael Ananin, Vytautas Vaitukaitis, Marc Paulina
-
Patent number: 9457090Abstract: Bioactive hydroforming luminal liner compositions are formed of an absorbable crystalline amphiphilic polyether-ester-urethane dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.Type: GrantFiled: April 7, 2014Date of Patent: October 4, 2016Assignee: Poly-Med, Inc.Inventors: Shalaby W. Shalaby, David Ingram, Georgios Hilas, Sheila Nagatomi
-
Publication number: 20160171486Abstract: Devices, systems and methods are disclosed which enable data processing in multiple environments including in electronic transaction type environments, and environments including wireless beacons. In the former, a machine-identifiable tag is utilized to initiate a transaction with an electronic device and various devices and systems supporting such a tag processing platform are described. In the latter, the electronic device can be utilized for configuration and processing of data pertaining to wireless beacons and various systems devices and systems supporting such a wireless beacon environment are described.Type: ApplicationFiled: July 10, 2014Publication date: June 16, 2016Inventors: Dan Wagner, David Ingram, Steve Butcher
-
Patent number: 9345704Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.Type: GrantFiled: November 18, 2014Date of Patent: May 24, 2016Assignee: Indiana University Research and Technology CorporationInventors: D. Wade Clapp, David Ingram, Feng-Chun Yang
-
Publication number: 20150072992Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.Type: ApplicationFiled: November 18, 2014Publication date: March 12, 2015Inventors: D. Wade Clapp, David Ingram, Feng-Chun Yang
-
Patent number: 8933082Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.Type: GrantFiled: September 20, 2013Date of Patent: January 13, 2015Assignee: Indiana University Research and Technology Corp.Inventors: D Wade Clapp, David Ingram, Feng-Chun Yang
-
Publication number: 20140221922Abstract: Bioactive hydroforming luminal liner compositions are formed of an absorbable crystalline amphiphilic polyether-ester-urethane dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.Type: ApplicationFiled: April 7, 2014Publication date: August 7, 2014Applicant: POLY-MED, INC.Inventors: Shalaby W. Shalaby, David Ingram, Georgios Hilas, Sheila Nagatomi
-
Publication number: 20140121214Abstract: Germline mutations in the NF1 tumor suppressor gene cause Von Recklinghausen's neurofibromatosis type 1 (NF1), a common genetic disorder of the nervous system characterized by plexiform neurofibroma development. Using adoptive transfer of hematopoietic cells, we establish that NF1 heterozygosity of bone marrow derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell nullizygosity. Further, genetic or pharmacologic attenuation of the c-kit signaling pathway in hematopoietic cells greatly diminishes neurofibroma initiation and progression. These studies identify haploinsufficient hematopoietic cells and the c-kit receptor as therapeutic targets for preventing plexiform neurofibromas and implicate mast cells as critical mediators of tumor initiation.Type: ApplicationFiled: September 20, 2013Publication date: May 1, 2014Applicant: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP.Inventors: D. Wade Clapp, David Ingram, Feng-Chun Yang
-
Patent number: 8691235Abstract: Bioactive hydroforming luminal liner compositions are formed of an absorbable crystalline amphiphilic polyether-ester-urethane dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.Type: GrantFiled: April 5, 2010Date of Patent: April 8, 2014Assignee: Poly-Med, Inc.Inventors: Shalaby W Shalaby, David Ingram, Georgios T Hilas, Sheila Nagatomi
-
Patent number: 8526920Abstract: A solution for notifying a user of alternate means of accessing voicemail data utilize a timer that can be set on a user device upon receipt of a message waiting indicator. When the timer expires, if no data communications connection has been established between the user device and a voicemail server, the user device can present alternate voicemail access instructions to the user. These instructions may be obtained from the message waiting indicator or may be stored on the user device. In another embodiment, a voicemail server sets a timer after sending a message waiting indicator to a user device. The voicemail server sends a message containing alternate voicemail access instructions if no connection has been established between the voicemail server and the user device upon expiration of the timer.Type: GrantFiled: May 29, 2012Date of Patent: September 3, 2013Assignee: AT&T Intellectual Property I, L.P.Inventors: Alison Raphael, David Ingram, Dionne Pignatiello
-
Publication number: 20120238249Abstract: A solution for notifying a user of alternate means of accessing voicemail data utilize a timer that can be set on a user device upon receipt of a message waiting indicator. When the timer expires, if no data communications connection has been established between the user device and a voicemail server, the user device can present alternate voicemail access instructions to the user. These instructions may be obtained from the message waiting indicator or may be stored on the user device. In another embodiment, a voicemail server sets a timer after sending a message waiting indicator to a user device. The voicemail server sends a message containing alternate voicemail access instructions if no connection has been established between the voicemail server and the user device upon expiration of the timer.Type: ApplicationFiled: May 29, 2012Publication date: September 20, 2012Applicant: AT&T Intellectual Property I, L.P.Inventors: Alison Raphael, David Ingram, Dionne Pignatiello